Analysts Just Increased Price Targets of These 5 Stocks

3. PMV Pharmaceuticals, Inc. (NASDAQ:PMVP)

Number of Hedge Fund Holders: 15

PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) has risen 2.64% as of 12:11 PM ET. Jeff Jones at Oppenheimer increased the price target on PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) from $30 to $33 and reiterated an Outperform rating on the stock after attending the company’s presentation during the 2022 American Society of Clinical Oncology (ASCO). PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) conducted a key opinion leader (KOL) event with Dr. Dumbrava of the University of Texas-based MD Anderson Cancer Center (MDACC). The expert provided positive views on the clinical data.

As of Q1 2022, PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) was held by 15 hedge funds.